 |
15 Diseases |  |
10 Trials |
|
10 Trials |  |
315 News |  |
| «12345 |
- ||| ibuprofen topical (TIB200) / Futura Medical, methyl salicylate and menthol (SPR300) / Futura Medical
New P1 trial: Assess the Efficacy and Safety in Volunteers of DCF100, TIB200 and SPR300 vs. Placebo and Control(s) in a UV Pain Model (clinicaltrials.gov) - Jan 28, 2016
P1, N=60, Completed, Sponsor: Futura Medical Developments Ltd.
- |||||||||| New P3 trial: A Randomized, Double-Blind, Parallel-Group, Vehicle-Controlled, Multicenter Study Comparing Diclofenac Sodium Gel, 3% to Solaraze® Gel, 3% in the Treatment of Actinic Keratosis on the Face or Bald Scalp (clinicaltrials.gov) - Nov 24, 2015
P3, N=475, Recruiting, Sponsor: Teva Pharmaceuticals USA
- |||| Enrollment open: Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp (clinicaltrials.gov) - Nov 16, 2015
P4, N=500, Recruiting, Sponsor: LEO Pharma
Not yet recruiting --> Recruiting
- |||||||||| New P3 trial: To Study Generic Diclofenac Sodium Topical Gel 1% in the Treatment of Osteoarthritis of the Knee (Degenerative Joint Disease Presented as Joint Pain, Stiffness, Swelling and Restricted Motion). (clinicaltrials.gov) - Nov 5, 2015
P3, N=1410, Recruiting, Sponsor: Glenmark Pharmaceuticals Ltd. India
- ||||||| Trial completion: Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries (clinicaltrials.gov) - Nov 3, 2015
P3, N=214, Completed, Sponsor: Novartis
Not yet recruiting --> Recruiting Recruiting --> Completed
- | diclofenac sodium topical / Generic mfg.
Trial completion: Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee (clinicaltrials.gov) - Jul 16, 2015
P3, N=1176, Completed, Sponsor: Amneal Pharmaceuticals, LLC
Recruiting --> Completed Recruiting --> Completed
- Trial primary completion date: Effects of Topical Diclofenac on Tumor Metabolism (clinicaltrials.gov) - Jul 6, 2015
P4, N=38, Active, not recruiting, Sponsor: University Hospital Regensburg
Recruiting --> Completed Trial primary completion date: Dec 2014 --> Oct 2015
- |||| Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Trial completion, Trial primary completion date: Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) (clinicaltrials.gov) - Apr 3, 2015
P4, N=221, Completed, Sponsor: MEDA Pharma GmbH & Co. KG
Trial primary completion date: Dec 2014 --> Oct 2015 Active, not recruiting --> Completed | Trial primary completion date: Aug 2015 --> Mar 2015
- ||||| New P4 trial: Efficacy and Safety of Ingenol Mebutate Gel 0.015% Compared to Diclofenac Sodium Gel 3% in Subjects With Actinic Keratoses on the Face or Scalp (clinicaltrials.gov) - Apr 1, 2015
P4, N=500, Not yet recruiting, Sponsor: LEO Pharma
- | menthol/diclofenac (MFC-51123) / GSK
Trial completion, Enrollment change: Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium (clinicaltrials.gov) - Feb 26, 2015
P1, N=18, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed | Trial primary completion date: Aug 2015 --> Mar 2015 Not yet recruiting --> Completed | N=40 --> 18
- |||||| Enrollment open: Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries (clinicaltrials.gov) - Jan 30, 2015
P3, N=200, Recruiting, Sponsor: Novartis
Not yet recruiting --> Completed | N=40 --> 18 Not yet recruiting --> Recruiting
- ||||||| Trial completion: A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness (clinicaltrials.gov) - Jan 30, 2015
P3, N=102, Completed, Sponsor: Novartis
Not yet recruiting --> Recruiting Recruiting --> Completed
- Vectical (calcitriol) / Nestle
Phase classification, IO biomarker: Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma (clinicaltrials.gov) - Jan 13, 2015
P2, N=128, Completed, Sponsor: Maastricht University Medical Center
Recruiting --> Completed Phase classification: P3 --> P2
- | diclofenac sodium topical / Generic mfg.
Trial completion: An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS (clinicaltrials.gov) - Dec 10, 2014
P4, N=24, Completed, Sponsor: Lotus Clinical Research, LLC
Phase classification: P3 --> P2 Recruiting --> Completed
- || Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Trial primary completion date: Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) (clinicaltrials.gov) - Nov 25, 2014
P4, N=220, Active, not recruiting, Sponsor: MEDA Pharma GmbH & Co. KG
Recruiting --> Completed Trial primary completion date: Jan 2016 --> Aug 2015
- |||||||||| New P3 trial: Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects With Acute Blunt Trauma Injuries (clinicaltrials.gov) - Nov 14, 2014
P3, N=200, Not yet recruiting, Sponsor: Novartis
- |||||||||| New P3 trial: A Within-subject Study to Evaluate the Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Compared to Placebo in Subjects Experiencing Delayed Onset Muscle Soreness (clinicaltrials.gov) - Oct 22, 2014
P3, N=86, Recruiting, Sponsor: Novartis
- Enrollment closed, Trial primary completion date: Effects of Topical Diclofenac on Tumor Metabolism (clinicaltrials.gov) - Sep 16, 2014
P4, N=38, Active, not recruiting, Sponsor: University Hospital Regensburg
Trial primary completion date: Jan 2016 --> Aug 2015 Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2014 --> Dec 2014
- Trial completion: KoGon: Cabbage Leaf Wraps in Osteoarthritis of the Knee (clinicaltrials.gov) - Aug 19, 2014
P=N/A, N=81, Completed, Sponsor: Universität Duisburg-Essen
Recruiting --> Active, not recruiting | Trial primary completion date: Mar 2014 --> Dec 2014 Active, not recruiting --> Completed
- | menthol/diclofenac (MFC-51123) / GSK
New P1 trial: Pharmacokinetics Study Comparing Topical Diclofenac/Menthol Gels With Voltaren Gel and Oral Diclofenac Sodium (clinicaltrials.gov) - Jul 28, 2014
P1, N=40, Not yet recruiting, Sponsor: GlaxoSmithKline
- |||||||||| diclofenac sodium topical / Generic mfg.
New P3 trial: Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee (clinicaltrials.gov) - Apr 21, 2014
P3, N=1176, Recruiting, Sponsor: Amneal Pharmaceuticals, LLC
- |||||| diclofenac sodium topical / Generic mfg.
Enrollment open: Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee (clinicaltrials.gov) - Apr 20, 2014
P3, N=1176, Recruiting, Sponsor: Amneal Pharmaceuticals, LLC
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- Enrollment closed: KoGon: Cabbage Leaf Wraps in Osteoarthritis of the Knee (clinicaltrials.gov) - Apr 9, 2014
P=N/A, N=81, Active, not recruiting, Sponsor: Universität Duisburg-Essen
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting
- | Vectical (calcitriol) / Nestle
Trial completion, IO biomarker: Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma (clinicaltrials.gov) - Mar 17, 2014
P3, N=128, Completed, Sponsor: Maastricht University Medical Center
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | diclofenac sodium topical / Generic mfg.
New P4 trial: An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS (clinicaltrials.gov) - Mar 12, 2014
P4, N=24, Recruiting, Sponsor: Lotus Clinical Research, LLC
- | diclofenac sodium topical / Generic mfg.
Enrollment open: An Investigator Initiated, Within-Subject, Proof of Concept Study to Assess the Efficacy and Safety of Voltaren Gel in Subjects With DOMS (clinicaltrials.gov) - Mar 12, 2014
P4, N=24, Recruiting, Sponsor: Lotus Clinical Research, LLC
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- |||||||||| diclofenac sodium topical / Generic mfg.
New P3 trial: Treatment of Knee Pain With Topical Diclofenac Cream 8% or Diclofenac Gel 1% (clinicaltrials.gov) - Feb 19, 2014
P3, N=106, Recruiting, Sponsor: FPR Specialty Pharmacy
- ||| Trial completion: A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis (clinicaltrials.gov) - Dec 18, 2013
P1, N=435, Completed, Sponsor: Taro Pharmaceuticals USA
Not yet recruiting --> Recruiting Recruiting --> Completed
- |||||||||| New P3 trial: A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis (clinicaltrials.gov) - Oct 14, 2013
P3, N=585, Completed, Sponsor: Actavis Inc.
- ||||||| Trial completion: A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis (clinicaltrials.gov) - Oct 10, 2013
P3, N=585, Completed, Sponsor: Actavis Inc.
Recruiting --> Completed Not yet recruiting --> Completed
- New P4 trial: Effects of Topical Diclofenac on Tumor Metabolism (clinicaltrials.gov) - Sep 3, 2013
P4, N=38, Recruiting, Sponsor: University Hospital Regensburg
- || New P3 trial: Multi-centre clinical trial to evaluate safety and efficacy of Diclofenac 1% gel vs. placebo gel in patients with acute traumatic blunt soft tissue injury/contusion of the limbs (EUDRACT) - Apr 29, 2013
P3, N=196, Ongoing, Sponsor: EPIFARMA SRL
- |||| Trial completion: The Efficacy of Diclofenac Gel for Breakthrough Pain and the Neuropathic Components of Pain in Knee Osteoarthritis (clinicaltrials.gov) - Apr 25, 2013
P4, N=60, Completed, Sponsor: Brigham and Women's Hospital
Not yet recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion: Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate (clinicaltrials.gov) - Mar 19, 2013
P4, N=40, Completed, Sponsor: Brown, Theodore R., M.D., MPH
Active, not recruiting --> Completed Recruiting --> Completed
- | New P4 trial, IO biomarker: Clinical effectiveness and effect on COX-2 expression of the sequential treatment of actinic keratoses (AK) with photodynamic therapy (PDT) and diclofenac 3% gel: a phase IV clinical trial Efectividad clínica y efecto sobre la expresión de COX-2 del tratamiento secuencial de queratosis actínicas con terapia fotodinámica y diclofenaco gel 3%. Ensayo clínico fase IV (EUDRACT) - Mar 5, 2013
P4, N=130, Ongoing, Sponsor: Fundacion para la investigación biomédica del hospital Ramón y Cajal de Madrid
- |||| Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Trial completion: LEIDA: Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (clinicaltrials.gov) - Jan 30, 2013
P4, N=258, Completed, Sponsor: MEDA Pharma GmbH & Co. KG
Recruiting --> Completed Active, not recruiting --> Completed
- ||| New P1 trial: A Study Comparing Diclofenac Sodium Gel 3% to Solaraze® Gel 3% in the Treatment of Actinic Keratosis (clinicaltrials.gov) - Dec 3, 2012
P1, N=435, Completed, Sponsor: Taro Pharmaceuticals USA
- || New P3 trial: Comparison of the Efficacy of Diclofenac Sodium Topical Gel, 1% (Mylan) to Voltaren® Gel, 1% (Novartis US) and Placebo in Adult Subjects with Knee Osteoarthritis (EUDRACT) - Jul 18, 2012
P3, N=400, Ongoing, Sponsor: Mylan Pharmaceuticals Inc.
- ||||||| Trial completion: Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1% (clinicaltrials.gov) - Jul 9, 2012
P3, N=749, Completed, Sponsor: Anchen Pharmaceuticals, Inc
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| Trial completion: TAASS-Traumeel Ointment and Gel Compared With a Topical NSAID in Athletes With Acute Ankle Sprain (clinicaltrials.gov) - Apr 24, 2012
P3, N=449, Completed, Sponsor: Biologische Heilmittel Heel GmbH
Active, not recruiting --> Completed Recruiting --> Completed
- ||| Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
Enrollment closed: Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) (clinicaltrials.gov) - Mar 25, 2012
P4, N=220, Active, not recruiting, Sponsor: MEDA Pharma GmbH & Co. KG
Recruiting --> Completed Recruiting --> Active, not recruiting
- | Vectical (calcitriol) / Nestle
Enrollment change, IO biomarker: Topical Vitamin D3, Diclofenac or a Combination of Both to Treat Basal Cell Carcinoma (clinicaltrials.gov) - Jan 22, 2012
P3, N=128, Completed, Sponsor: Maastricht University Medical Center
Recruiting --> Active, not recruiting N=64 --> 128
- |||||||||| New P3 trial: Evaluation of Clinical Endpoints of Two Diclofenac Sodium Gel 1% (clinicaltrials.gov) - Oct 19, 2011
P3, N=749, Completed, Sponsor: Anchen Pharmaceuticals, Inc
- | New P4 trial: Diclofenac Sodium Topical Gel to Reduce Injection Site Discomfort in Patients Taking Glatiramer Acetate (clinicaltrials.gov) - Oct 17, 2011
P4, N=40, Completed, Sponsor: Brown, Theodore R., M.D., MPH
- ||||| Zyclara (imiquimod) / Mochida, Viatris, Bausch Health
New P4 trial: Long-term Effects of Imiquimod and Diclofenac in Actinic Keratoses (LEIDA 2) (clinicaltrials.gov) - Oct 13, 2011
P4, N=220, Active, not recruiting, Sponsor: MEDA Pharma GmbH & Co. KG
- ||||||| Trial completion: Efficacy and Safety of Diclofenac Sodium Topical Gel 1% Applied Four Times Daily in Subjects With Acute Ankle Sprain (clinicaltrials.gov) - Sep 7, 2011
P3, N=205, Completed, Sponsor: Novartis
N=64 --> 128 Recruiting --> Completed
- diclofenac sodium topical / Generic mfg.
New P2 trial: Effect of CD08100/02 3% gel versus placebo gel in subjects presenting with papulopustular rosacea over a 6-week treatment period. (EUDRACT) - Sep 6, 2011
P2, N=50, Completed, Sponsor: Galderma R&D SNC
- || New P3 trial: Vergleich eines bekannten Arzneimittels zur Behandlung der aktinischen Keratose (eine durch langzeitige Sonneneinwirkung hervorgerufene Hauterkrankung) mit einem neuen Arzneimittel (mit gleichem Wirkstoff) und der Grundlage ohne Wirkstoff. (EUDRACT) - Aug 31, 2011
P3, N=330, Ongoing, Sponsor: Dermapharm AG
- diclofenac sodium topical / Generic mfg.
Trial completion: Comparison of the Efficacy and Tolerability of Solaraze for 3 Versus 6 Months in Patients With Mild to Moderate Actinic Keratosis Located on the Face and Head (clinicaltrials.gov) - Aug 17, 2011
P4, N=418, Completed, Sponsor: University Hospital Tuebingen
Recruiting --> Completed Active, not recruiting --> Completed